METHOD OF TREATING PROSTATE CANCER Russian patent published in 2010 - IPC A61N5/10 A61B18/04 A61F7/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, oncology, and can be used for treating prostate cancer. Therefore, the treatment is two-staged. The first stage involves gamma therapy with fractionated dose. First three days, the dose is 4 Gy. Then five times a week, the dose is 2 Gy to the total focal dose 38 Gy. In the 4^th, 6^th, 9^th, 11^th, 14^th days, no more than 60 minutes prior to each session of gamma therapy, radiomodification by transurethral thermotherapy is performed. Herewith radiomodification is preceded with trial catheterisation of urinary bladder and urethral anaesthesia by introduction of 2-4 ml of mixed lidocaine-glycerine. The mixure is prepared at 2.0 of 2% lidocaine and 10.0 of glycerine. Thermotherapy is performed in a radio-frequency range at frequency 40.46 mHz with maximum power 40 Wt and duration of one session 60 minutes. The same procedure is applied for transurethral thermotherapy at the second stage of treatment after a fortnight break. At the second stage, remote gamma therapy is also performed five times a week in a dose 2 Gy to the total focal dose 68 Gy.

EFFECT: method enables adequate anaesthesia during sessions of thermotherapy, prevention of such complications as urethritis, urethral strictures, improves clinical effectiveness for prostate cancer of I, II, III stages.

3 ex